Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover study
Conclusions Overall, this study provides reassurance over the cardiovascular safety of extrafine BDP/FF, both in a DPI and a pMDI formulation.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
More News: Asthma | Cardiology | Cardiovascular | Chronic Obstructive Pulmonary | Drugs & Pharmacology | Eyes | Heart | Respiratory Medicine | Statistics | Study